Novartis AG

NVS
96,00
0,12 (0,13%)
29 Mar 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/2/202422:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
06/2/202422:52EDGAR2Form SC TO-C - Written communication relating to an issuer..
06/2/202412:14IHMARKETNEWSBoeing Faces Strike Threat, Palantir Up 18% After Recording..
05/2/202423:06EDGAR2Form SC TO-C - Written communication relating to an issuer..
02/2/202420:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202413:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/1/202413:42EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
31/1/202413:38EDGAR2Form 20-F - Annual and transition report of foreign private..
31/1/202412:28IHMARKETNEWSWalmart’s Stock Split, Elon Musk’s Billion-Dollar Package..
22/1/202407:59DJNSandoz to Acquire Cimerli Business from Coherus for $170..
12/1/202412:10IHMARKETNEWSWall Street Highlights: DocuSign Acquisition Battle, Tesla..
11/1/202419:02DJNCytokinetics Shares Slide as Novartis Reportedly Shies Away..
08/1/202419:43DJNCytokinetics Shares Jump 16% After WSJ Report of Novartis..
08/1/202416:41DJNNovartis on Track for Record High Close -- Data Talk
08/1/202412:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202408:01DJNNovartis's Scemblix Drug Meets Main Goals in Late-Stage..
05/1/202416:15DJNNovartis to Make Pluvicto Radioligand Therapy at..
02/1/202413:46DJNVoyager Therapeutics Shares Leap Premarket on Novartis..
11/12/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202308:02DJNNovartis Drug Meets Primary Goal in Late-Stage Study for..
11/12/202301:39PRNUSNovartis presents new 48-week results from Phase III..
06/12/202311:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
06/12/202306:18PRNUSNovartis receives FDA approval for Fabhalta® (iptacopan),..
05/12/202312:25IHMARKETNEWSMoody’s Reassesses China, GitLab Exceeds Estimates, Twilio..
29/11/202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28/11/202321:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202312:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202308:12DJNNovartis Raises Mid-Term Sales Growth Targets
13/11/202315:16DJNLegend Biotech Subsidiary in License Agreement With Novartis
01/11/202313:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202307:43DJNNovartis Skin Treatment Drug Cosentyx Gets US FDA Approval
30/10/202311:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202308:07DJNNovartis to Seek US Accelerated Approval of Atrasentan After..
27/10/202307:45DJNNovartis Says FDA Deems Pluvicto Shortage Resolved, Supply..
24/10/202313:22IHMARKETNEWSTuesday’s Wall Street Highlights: Coinbase, Intel, Redfin,..
24/10/202312:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202309:32DJNNovartis Raises Earnings Guidance Again After Key Drugs..
24/10/202307:48DJNNovartis Raises Earnings Guidance After Key Drugs Boost..
06/10/202323:11DJNNovartis Gets FDA Approval IV Formulation of Cosentyx
04/10/202312:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/10/202311:17DJNNovartis Spinoff Sandoz Group Valued at $11.2 Billion in..
02/10/202312:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/10/202308:10DJNNovartis Says Kidney Drug Phase 3 Trial Reaches Positive..
26/9/202308:03DJNNovartis's Sandoz to Commercialize Multiple Sclerosis..
25/9/202313:17IHMARKETNEWSMonday’s Wall Street Highlights: Ford, Amazon, Paramount,..
25/9/202308:08DJNNovartis's Radioligand Therapy Shows Survival Improvement..
19/9/202322:08EDGAR2Form 144 - Report of proposed sale of securities
18/9/202308:16DJNNovartis Cancer Drug Gets Marketing Recommendation from..
15/9/202315:32IHMARKETNEWSFriday’s Wall Street Highlights: Ford Motor, Arm,..
Apertura: 96,31 Min: 96,15 Max: 97,20
Chiusura: 95,88

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network